Longboard Pharmaceuticals to Participate in Five Upcoming Epilepsy-Focused Conferences this Summer
01 juin 2022 08h30 HE
|
Longboard Pharmaceuticals, Inc.
SAN DIEGO, June 01, 2022 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for...